FDA panel backs easier access to peptides

NPR | By Will Stone

Published July 24, 2026 at 4:43 AM MDT

Facebook
Flipboard
LinkedIn
Email

Advisers to the Food and Drug Administration are backing popular peptide therapies. They voted to allow specialized pharmacies to make them despite agency scientists' recommendations against it.

Facebook
Flipboard
LinkedIn
Email

Will Stone

Make a monthly donation

Become a sustaining member for as low as $5/month

Make a one-time donation

Make an annual or one-time donation to support MTPR

Pay pledge or update info

Pay an existing pledge or update your payment information